ICTS Investigator Aims to Implement Widespread Use of Visual Key Information for Informed Consent in Research Studies

Ever since Mary Politi, PhD, arrived at WashU back in 2009, she has believed the informed consent process for research study participants could be improved. Many people who think about joining research studies comment on the length and complexity of informed consent documents. They often assume these documents are used for legal purposes rather than […]

Former KL2 Scholar Awarded NIA Funding for Alzheimer’s Caregiver Research

Jacquelyn Benson, PhD, Associate Professor of Medicine in the WashU Division of Palliative Medicine, has recently been awarded funding from the National Institute on Aging to conduct a randomized controlled trial to test a 1:1, paraprofessional peer-delivered multicomponent support intervention for family caregivers of persons living with Alzheimer’s disease (AD). This intervention is designed to […]

WashU Investigator credits ICTS resources and funding on her path to $2.8 million grant from the National Institutes of Health (NIH)

Christine O’Brien, PhD, an assistant professor of biomedical engineering at Washington University in St. Louis, was recently granted $2.8 million from the NIH to develop a wearable device to track blood loss to prevent postpartum hemorrhage – the leading cause of maternal death worldwide. The goal is to design a wearable device that tracks blood […]

ICTS Extends its Gratitude and Bids Farewell to Longtime Associate Director

""

Effective September 1, 2025, Christina Gurnett, MD, PhD, will begin her tenure as Head of the Division of Pediatric Neurology at the Children’s Hospital of Philadelphia and the University of Pennsylvania. Dr. Gurnett, the A. Ernest & Jane G. Stein Professor of Neurology, began her journey at Washington University and St. Louis Children’s Hospital in […]

ICTS-supported facility accelerates translation of promising research into improving outcomes for cancer and other related diseases

""

Housed within the Siteman Cancer Center, the Biologic Therapy Core Facility (BTCF) partners with physicians and scientists to manufacture, characterize, and release complex, clinical-grade cell and gene therapy products, imaging agents, and other biologics to support early-phase clinical trials. The BTCF also supports cellular (e.g. hematopoietic stem cell selections) and tissue therapies (e.g. parathyroid cryopreservation) […]

WashU Investigator credits ICTS-related programs and funding mechanisms with career development and research advancement

""

For James Krings, MD, MSCI, Assistant Professor of Medicine in the Division of Pulmonary & Critical Care, settling in at WashU for his career in scientific research seems always to have been written in the stars. Originally from St. Louis, MO, Krings returned home after attending medical school at Stanford University and completing his residency […]

WashU Investigator utilizes and nurtures community-based relationships to propel research and serve local communities

For investigators, there is much to be considered when choosing how to conduct research projects. Which demographics will you target? Which funding mechanisms should you apply for? How long will it take you to accomplish your aims? One of the most important considerations that seems simple enough, though it can sometimes appear unfamiliar to investigators, […]

ICTS Highlights Impacts Made from COVID-19 Biorepository

''

In the early days of the COVID-19 pandemic, it became immediately clear to the worldwide scientific and research communities that a dire need was evolving to discover effective treatments for a rapidly increasing number of infected patients. But before the St. Louis region had even seen its first case of COVID-19, WashU researchers were already […]

ICTS-funded investigator conducts crucial research to better understand, diagnose, and treat rare genetic disease

Dr. Fumihiko Urano

Rare diseases are just what their name implies – each one affects a limited number of people. But with this rarity comes unique challenges, and among the biggest challenges faced by these patients are the roadblocks they encounter with gathering information about their conditions, being properly diagnosed, and finding the best resources and treatment options […]

ICTS investigators optimize methods of treatment for blood cancers through genome sequencing test

Drs. Duncavage and Spencer

When it comes to pinpointing the best courses of treatment for cancer patients, there is always room for improvement. That has been the belief for two investigators at the Washington University School of Medicine, leading them to the groundbreaking development of a genomic sequencing test that captures a full picture of patient-specific data. This provides […]